164 related articles for article (PubMed ID: 21460633)
1. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.
Wallington-Beddoe CT; Hewson J; Bradstock KF; Bendall LJ
Autophagy; 2011 Jul; 7(7):707-15. PubMed ID: 21460633
[TBL] [Abstract][Full Text] [Related]
2. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.
Zhang N; Qi Y; Wadham C; Wang L; Warren A; Di W; Xia P
Autophagy; 2010 Nov; 6(8):1157-67. PubMed ID: 20935520
[TBL] [Abstract][Full Text] [Related]
3. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
Liu Q; Zhao X; Frissora F; Ma Y; Santhanam R; Jarjoura D; Lehman A; Perrotti D; Chen CS; Dalton JT; Muthusamy N; Byrd JC
Blood; 2008 Jan; 111(1):275-84. PubMed ID: 17761520
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Oaks JJ; Santhanam R; Walker CJ; Roof S; Harb JG; Ferenchak G; Eisfeld AK; Van Brocklyn JR; Briesewitz R; Saddoughi SA; Nagata K; Bittman R; Caligiuri MA; Abdel-Wahab O; Levine R; Arlinghaus RB; Quintas-Cardama A; Goldman JM; Apperley J; Reid A; Milojkovic D; Ziolo MT; Marcucci G; Ogretmen B; Neviani P; Perrotti D
Blood; 2013 Sep; 122(11):1923-34. PubMed ID: 23926298
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of ROS in U266 cell death induced by FTY720].
Li YC; Liu ZG; Yao K; Wang HH; Hu R; Yang W; Liao AJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):643-6. PubMed ID: 23815914
[TBL] [Abstract][Full Text] [Related]
6. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
7. Autophagy induced by FTY720 promotes apoptosis in U266 cells.
Liao A; Hu R; Zhao Q; Li J; Li Y; Yao K; Zhang R; Wang H; Yang W; Liu Z
Eur J Pharm Sci; 2012 Apr; 45(5):600-5. PubMed ID: 22281442
[TBL] [Abstract][Full Text] [Related]
8. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
Zhang L; Wang H; Ding K; Xu J
Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952
[TBL] [Abstract][Full Text] [Related]
9. [Influence of PP2A activator on proliferation of HL-60 cells and analysis of PP2A activity changes in patients with acute myeloid leukemia].
Yang Y; Li XQ; Huang Q; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):594-7. PubMed ID: 21729530
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
Omar HA; Chou CC; Berman-Booty LD; Ma Y; Hung JH; Wang D; Kogure T; Patel T; Terracciano L; Muthusamy N; Byrd JC; Kulp SK; Chen CS
Hepatology; 2011 Jun; 53(6):1943-58. PubMed ID: 21391227
[TBL] [Abstract][Full Text] [Related]
11. FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism.
Bai LY; Chiu CF; Chiu SJ; Chu PC; Weng JR
Sci Rep; 2017 Jul; 7(1):5600. PubMed ID: 28717222
[TBL] [Abstract][Full Text] [Related]
12. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
Alinari L; Mahoney E; Patton J; Zhang X; Huynh L; Earl CT; Mani R; Mao Y; Yu B; Quinion C; Towns WH; Chen CS; Goldenberg DM; Blum KA; Byrd JC; Muthusamy N; Praetorius-Ibba M; Baiocchi RA
Blood; 2011 Dec; 118(26):6893-903. PubMed ID: 22042694
[TBL] [Abstract][Full Text] [Related]
13. Involvement of vacuolar H(+)-ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720.
Tay KH; Liu X; Chi M; Jin L; Jiang CC; Guo ST; Verrills NM; Tseng HY; Zhang XD
Pigment Cell Melanoma Res; 2015 Mar; 28(2):171-83. PubMed ID: 25358761
[TBL] [Abstract][Full Text] [Related]
14. PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.
Cristóbal I; Manso R; Rincón R; Caramés C; Senin C; Borrero A; Martínez-Useros J; Rodriguez M; Zazo S; Aguilera O; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Mol Cancer Ther; 2014 Apr; 13(4):938-47. PubMed ID: 24448818
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria.
Nagahara Y; Ikekita M; Shinomiya T
J Immunol; 2000 Sep; 165(6):3250-9. PubMed ID: 10975841
[TBL] [Abstract][Full Text] [Related]
16. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
17. FTY720 stimulated ROS generation and the Sty1/Atf1 signaling pathway in the fission yeast Schizosaccharomyces pombe.
Hagihara K; Mizukura A; Kitai Y; Yao M; Ishida K; Kita A; Kunoh T; Masuko T; Matzno S; Chiba K; Sugiura R
Genes Cells; 2014 Apr; 19(4):325-37. PubMed ID: 24506481
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.
Saddoughi SA; Gencer S; Peterson YK; Ward KE; Mukhopadhyay A; Oaks J; Bielawski J; Szulc ZM; Thomas RJ; Selvam SP; Senkal CE; Garrett-Mayer E; De Palma RM; Fedarovich D; Liu A; Habib AA; Stahelin RV; Perrotti D; Ogretmen B
EMBO Mol Med; 2013 Jan; 5(1):105-21. PubMed ID: 23180565
[TBL] [Abstract][Full Text] [Related]
19. Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Wallington-Beddoe CT; Don AS; Hewson J; Qiao Q; Papa RA; Lock RB; Bradstock KF; Bendall LJ
PLoS One; 2012; 7(5):e36429. PubMed ID: 22570713
[TBL] [Abstract][Full Text] [Related]
20. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Li MH; Hla T; Ferrer F
Pediatr Blood Cancer; 2013 Sep; 60(9):1418-23. PubMed ID: 23704073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
